Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Silberbauer

Showing results (1-10 of 116) with videos related to

Pageof 12
Sort By:
Acta Medica Austriaca|January 8, 1999
[Cardiovascular sequelae and risks of obesity]K Silberbauer
Nephron|March 2, 1999
Erythropoietin response to folic acid substitutionW Pronai, K Silberbauer
Acta Medica Austriaca|January 1, 1984
[Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension]B Stanek, K Silberbauer
Thrombosis Research|December 1, 1978
Cortex and medulla of rat kidney generate different amounts of PG I2-like activityK Silberbauer, H Sinzinger
Wiener Klinische Wochenschrift|December 10, 1982
[Dose-dependent increase in prostacyclin synthesis from various vascular tissues by dipyridamole]H Sinzinger, K Silberbauer
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1981
[Current status of the prostacyclin story for clinical use]H Sinzinger, K Silberbauer
Basic Research in Cardiology|May 1, 1986
Effect of angiotensin II infusion on a prostaglandin I2-metabolite and on left ventricular functionC Punzengruber, K Silberbauer
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1985
[Takayasu arteritis--Kimoto type II. Case report]M Frass, K Silberbauer
Nephron|January 1, 1986
Acute and chronic effects of captopril on bicyclo-PGEm, the stable bicyclic end product of prostaglandin E2 in essential hypertensionB Stanek, K Silberbauer
Cardiology|January 1, 1983
Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failureK Silberbauer, C Punzengruber, H Sinzinger
Pageof 12

Showing results (1-10 of 116) with videos related to

Sort By:
Pageof 12
Acta Medica Austriaca|January 8, 1999
[Cardiovascular sequelae and risks of obesity]K Silberbauer
Nephron|March 2, 1999
Erythropoietin response to folic acid substitutionW Pronai, K Silberbauer
Acta Medica Austriaca|January 1, 1984
[Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension]B Stanek, K Silberbauer
Thrombosis Research|December 1, 1978
Cortex and medulla of rat kidney generate different amounts of PG I2-like activityK Silberbauer, H Sinzinger
Wiener Klinische Wochenschrift|December 10, 1982
[Dose-dependent increase in prostacyclin synthesis from various vascular tissues by dipyridamole]H Sinzinger, K Silberbauer
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1981
[Current status of the prostacyclin story for clinical use]H Sinzinger, K Silberbauer
Basic Research in Cardiology|May 1, 1986
Effect of angiotensin II infusion on a prostaglandin I2-metabolite and on left ventricular functionC Punzengruber, K Silberbauer
VASA. Zeitschrift Fur Gefasskrankheiten|January 1, 1985
[Takayasu arteritis--Kimoto type II. Case report]M Frass, K Silberbauer
Nephron|January 1, 1986
Acute and chronic effects of captopril on bicyclo-PGEm, the stable bicyclic end product of prostaglandin E2 in essential hypertensionB Stanek, K Silberbauer
Cardiology|January 1, 1983
Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failureK Silberbauer, C Punzengruber, H Sinzinger
Pageof 12